<DOC>
	<DOCNO>NCT00790790</DOCNO>
	<brief_summary>To gather data whether new drug osteoarthritis knee pain safe effect pain level .</brief_summary>
	<brief_title>A Study Treatment Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Present Osteoarthritis ( OA ) knee base : 1 ) Knee pain least 14 day per month last 3 month , 2 ) Osteophytes ( bone spur ) , 3 ) And least 1 follow : Over age 50 , OR morning stiffness knee le 30 minute , OR crunch sensation knee bend back forth ( crepitus ) . Mean score 4 great 24hour average pain score Visit 2 Visit 3 . Completion electronic daily diary least 70 % complete Visit 2 Visit 3 . Taken nonsteroidal antiinflammatory drug ( NSAIDs ) less 15 day past month AND take NSAIDs least 1 week prior Visit 3 . Agree maintain activity level throughout study . Women become pregnant must test negative pregnancy agree utilize medically acceptable/reliable birth control study 1 month follow last dose study . Competent freely able give inform consent . Ability understand intelligibly communicate investigator . Judged reliable agree keep appointment clinic visit , test , procedure require protocol . Knee arthroscopy within past 3 month knee joint replacement . Surgery plan trial knee study . Prior synovial fluid analysis show white blood cell 2000 cubic millimeter ( mm^3 ) indicative diagnosis OA Are nonambulatory require use crutch walker . Use cane hand opposite index knee acceptable . Body Mass Index 40 . Confounding painful condition may interfere assessment index knee . ( Knee pain predominant pain . Mild OA hand allow , instance . ) Diagnosis inflammatory arthritis ( rheumatoid arthritis ) autoimmune disorder ( except inactive Hashimoto 's thyroiditis ) . Received intraarticular hyaluronate steroid , joint lavage , invasive therapy knee past 3 month . Frequent fall could result hospitalization could compromise response treatment . Current previous ( within past 1 year ) Axis 1 diagnosis major depressive disorder , mania , bipolar disorder , psychosis , dysthymia , anxiety disorder , alcohol eating disorder . Serious unstable cardiovascular , hepatic , renal , respiratory , ophthalmologic , gastrointestinal , hematologic illness , symptomatic peripheral vascular disease , medical condition opinion investigator would compromise participation likely lead hospitalization course study . Alanine transaminase ( ALT ) &gt; 2.0 time upper limit normal Visit 1 , base reference range central lab . Prior renal transplant , current renal dialysis , serum creatinine laboratory value &gt; 1.5 time upper limit normal base reference range central lab . Diagnosis past history glaucoma . Subjects intraocular pressure &gt; 24 millimeter mercury ( mm Hg ) . Are take excluded medication discontinue Visit 1 . History substance abuse dependence within past year , exclude nicotine caffeine . Have positive urine drug screen substance abuse exclude medication . History recurrent seizure febrile seizure . Are judged investigator suicidal risk . History frequent and/or severe allergic reaction multiple medication . Pregnant breastfeeding . Are unwilling/unable comply use data collection device . Received treatment within last 30 day drug receive regulatory approval indication time study entry . Investigator site personnel directly affiliate study , and/or immediate family , Lilly employee . History severe delay stomach empty ( gastroparesis ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>